Hepatic fibrosis and short-term clinical efficacy after hepatic artery embolization for unresectable hepatocellular carcinoma using doxorubicin-eluting HepaSphere

BACKGROUND: Hepatocellular carcinoma (HCC) is most common malignancies around world. Transcatheter arterial chemoembolization (TACE) is recognized as the first-line treatment for HCC by NCCN, and its efficacy is widely reported. However, repeated TACE induces hepatic fibrosis. How to reduce hepatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Meng, Xu, Rongde, Chen, Xiaoming, Mai, Qicong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798776/
https://www.ncbi.nlm.nih.gov/pubmed/35117484
http://dx.doi.org/10.21037/tcr.2020.01.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798776/
https://www.ncbi.nlm.nih.gov/pubmed/35117484
http://dx.doi.org/10.21037/tcr.2020.01.15

Ejemplares similares